Literature DB >> 31147618

Eyelid sebaceous carcinoma: Validation of the 8th edition of the American Joint Committee on cancer T staging system and the prognostic factors for local recurrence, nodal metastasis, and survival.

Yun Hsia1, Ching-Yuan Yeh2, Yi-Hsuan Wei1, Lily-Wei Chen3, Shu-Lang Liao4,5.   

Abstract

PURPOSE: To investigate the clinicopathological features and prognostic factors for eyelid sebaceous gland carcinoma (SGC) in an ethnic Chinese population and to validate the performance of the T category of the 8th edition AJCC staging systems, with the aim of providing information for refinements.
METHODS: Sixty-three patients with pathological diagnosis of SGC were enroled retrospectively. The clinicopathological features, treatments, and outcomes were collected. Prognostic factors associated with the outcome of local recurrence, regional lymph node metastasis, and tumour-related death were analysed. The performance analysis was performed by comparing the predictive value for survival and the monotonicity of gradients between the 7th and 8th staging systems.
RESULTS: The distribution of T1:T2:T3:T4 tumours according to the 7th and 8th edition was 6:40:16:1 and 23:26:5:9, respectively. Positive surgical margin was a poor prognostic factor. Local recurrence was associated with more aggressive histopathological features and surrounding structure invasions. Regional lymph node metastasis was associated with larger tumours. The T category of 8th edition showed better predictability for local recurrence and regional lymph node metastasis, while the T category of 7th edition had better monotonicity of gradients. Tumours classified as T2c or worse had higher risk of regional lymph node metastasis, while tumours T3b or worse in the 8th edition had more tumour-related death.
CONCLUSIONS: Patients with higher T category are at risk of regional lymph node metastasis and tumour-related death. Further refinement of the T category of AJCC staging system can focus on the predictability for local recurrence and the monotonicity of gradients.

Entities:  

Mesh:

Year:  2019        PMID: 31147618      PMCID: PMC6707162          DOI: 10.1038/s41433-019-0454-7

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  18 in total

1.  Discrimination value of the new western prognostic system (CLIP score) for hepatocellular carcinoma in 662 Japanese patients. Cancer of the Liver Italian Program.

Authors:  S Ueno; G Tanabe; K Sako; T Hiwaki; H Hokotate; Y Fukukura; Y Baba; Y Imamura; T Aikou
Journal:  Hepatology       Date:  2001-09       Impact factor: 17.425

2.  Clinicopathological analysis of malignant eyelid tumor cases at Yamagata university hospital: statistical comparison of tumor incidence in Japan and in other countries.

Authors:  Hiroshi Takamura; Hidetoshi Yamashita
Journal:  Jpn J Ophthalmol       Date:  2005 Sep-Oct       Impact factor: 2.447

3.  Malignant eyelid tumors in an Indian population.

Authors:  R Sihota; K Tandon; S M Betharia; R Arora
Journal:  Arch Ophthalmol       Date:  1996-01

4.  Risk Factors for Local Recurrence or Metastasis of Eyelid Sebaceous Gland Carcinoma After Wide Excision With Paraffin Section Control.

Authors:  Yasuhiro Takahashi; Emiko Takahashi; Shunsuke Nakakura; Yoshiyuki Kitaguchi; Jacqueline Mupas-Uy; Hirohiko Kakizaki
Journal:  Am J Ophthalmol       Date:  2016-08-31       Impact factor: 5.258

5.  Patterns of lymphatic spread and the management of eyelid carcinomas.

Authors:  Kazuki Hashimoto; Ryuji Yasumatsu; Satoshi Toh; Hideki Shiratsuchi; Takamasa Yoshida; Kazuo Nishiyama; Hiroshi Yoshikawa; Torahiko Nakashima; Takashi Nakagawa
Journal:  Auris Nasus Larynx       Date:  2016-03-07       Impact factor: 1.863

6.  Outcome of patients with periocular sebaceous gland carcinoma with and without conjunctival intraepithelial invasion.

Authors:  A N Chao; C L Shields; H Krema; J A Shields
Journal:  Ophthalmology       Date:  2001-10       Impact factor: 12.079

7.  Malignant eyelid tumours in Taiwan.

Authors:  J-K Wang; S-L Liao; J-R Jou; P-C Lai; S C S Kao; P-K Hou; M-S Chen
Journal:  Eye (Lond)       Date:  2003-03       Impact factor: 3.775

8.  Intracranial extension of meibomian gland carcinoma with pagetoid changes.

Authors:  Yasuhiko Hayashi; Hiroshi Shima; Daisuke Kita; Masashi Kinoshita; Yuya Yoshida; Mitsuhiro Hasegawa; Jun-ichiro Hamada
Journal:  J Clin Neurosci       Date:  2009-02-05       Impact factor: 1.961

9.  Sebaceous carcinomas of the ocular adnexa: A clinicopathologic study of 104 cases, with five-year follow-up data.

Authors:  N A Rao; A A Hidayat; I W McLean; L E Zimmerman
Journal:  Hum Pathol       Date:  1982-02       Impact factor: 3.466

10.  Sebaceous carcinoma in Japanese patients: clinical presentation, staging and outcomes.

Authors:  Akihide Watanabe; Michelle T Sun; Adnan Pirbhai; Kosuke Ueda; Nobutada Katori; Dinesh Selva
Journal:  Br J Ophthalmol       Date:  2013-09-13       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.